Arrow
Arrow
Доктора Лив
Arrow
Проф. д.м.н. Meral Günaldı
Проф. д.м.н. Meral Günaldı
Проф. д.м.н.

Meral Günaldı

Liv Hospital Ulus
Медицинская онкология
Области интересов
    • Рак молочной железы
    • Рак яичников
    • Рак матки
    • Опухоль шейки матки
    • Рак легких
    • Рак толстой кишки
    • Рак поджелудочной железы
    • Многоформная глиобластома
    • Опухоли головного мозга
Резюме
Публикации
Членство
Награды
Посещенные курсы
21
h-index
Образование:
  • Бакалавриат: Медицинский факультет, Черноморский технический университет (1994–2001)
  • Специализация в медицине: Внутренние болезни, Окмейданьский учебный исследовательский госпиталь (2004–2009)
  • Дополнительная специализация: медицинская онкология, медицинский факультет Университета Чукурова (2009–2013)
  • Доцент: внутренние болезни, Университет Аджибадем (2016)
  • Профессор: Стамбульский университет Айдын (2022)
Опыт работы:
  • 2001–2002: Бартын, село Гёчгюн Демирджи, Козцагызский центральный медицинский пункт (врач общей практики)
  • 2002–2003: Стамбульский университет, медицинский факультет, кафедра неврологии (ассистент)
  • 2004–2009: Окмейданьский научно-исследовательский госпиталь, внутренние болезни (ассистент)
  • 2009–2013: Медицинский факультет Университета Чукурова, медицинская онкология (ассистент)
  • 2013–2016: Стамбул, Бакиркёй, Учебная и исследовательская больница им. д-ра Сади Конука (специалист по медицинской онкологии)
  • 2016–2018: Частный медицинский центр Neolife (доцент)
  • 2017–2023: Медицинский факультет Университета Айдын в Стамбуле, больница Флория Медикал Парк (доцент/профессор)
  • 2023–2025: Больница Медикана Атакёй (профессор, специалист по медицинской онкологии)
  • 2025–...: Больница Лив Улус
Статьи, Опубликованные в Международных Рецензируемых Журналах:
  • Günaldi, M., Helvaci, A., Yildirim, N. D., Kiskaç, M., & Küçükkaya, R. D. (2009). Acute myocardial infarction in a patient with hemophilia A and factor V Leiden mutation. Cardiology Journal, 16(5), 458–461.
  • Duman, B. B., Kara, I. O., Günaldi, M., & Erçolak, V. (2011). Primary cutaneous small-cell carcinoma: A case report. Medical Oncology, 28(Suppl 1), S634–S635. https://doi.org/10.1007/s12032-010-9672-3
  • Duman, B. B., Kara, I. O., Günaldi, M., & Ercolak, V. (2011). Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature. Archives of Gynecology and Obstetrics, 283(6), 1363–1368. https://doi.org/10.1007/s00404-011-1845-6
  • Gunaldi, M., Helvaci, A., Demirel Yildirim, N., Aydin, D., & Kara, N. (2011). Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3. Journal of BUON, 16(4), 778.
  • Günaldi, M., Oguz Kara, I., Duman, B. B., & Gumurdulu, D. (2012). Primary intrapulmonary thymoma associated with myasthenia gravis. General Thoracic and Cardiovascular Surgery, 60(9), 610–613. https://doi.org/10.1007/s11748-012-0064-9
  • Duman, B. B., Paydas, S., Tetiker, T., Gunaldı, M., Afsar, C. U., Erçolak, V., Haksöyler, V., & Dilli, M. Ş. (2012). Capecitabine-induced hypertriglyceridemia and hyperglycemia: Two cases. Pharmacology, 90(3–4), 212–215. https://doi.org/10.1159/000342382
  • Duman, B. B., Afşar, Ç. U., Günaldi, M., Sahin, B., Kara, I. O., Erkisi, M., & Erçolak, V. (2012). Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Asian Pacific Journal of Cancer Prevention, 13(8), 4119–4123.
  • Duman, B. B., Gunaldi, M., Ercolak, V., Afsar, C. U., Sahin, B., Erkisi, I. M., Kara, O., Paydas, S., Gönlüsen, G., & Sertdemir, Y. (2012). Retrospective analysis of 498 primary soft tissue sarcomas in a single Turkish centre. Asian Pacific Journal of Cancer Prevention, 13(8), 4125–4128.
  • Gunaldi, M., Kara, I. O., Duman, B. B., & Ercolak, V. (2012). Primary intracerebral myeloid sarcoma. Onkologie, 35(11), 694–697. https://doi.org/10.1159/000343953
  • Günaldi, M., Paydas, S., & Afsar, C. U., & Doran, F. (2013). Coexistence of tuberous sclerosis complex and malignant melanoma. Singapore Medical Journal, 54(11), e233–e235.
  • Günaldı, M., Paydaş, S., Usul Afşar, C., Bozkurt Duman, B., & Erçolak, V., Haksöyler, V. (2013). Carbamazepine and multiple myeloma: Possible interaction. Turkish Journal of Haematology, 30(1), 83–84. https://doi.org/10.4274/tjh.2012.0153
  • Usul Afşar, C., Paydaş, S., Günaldı, M., Bozkurt Duman, B., Erçolak, V., Zorludemir, S., & Açıkalın, A. (2013). Sweet syndrome in a patient with chronic lymphocytic leukemia/small lymphocytic lymphoma: Curious lymphocyte/neutrophil fluctuations. Turkish Journal of Haematology, 30(4), 413–415. https://doi.org/10.4274/Tjh.2012.0055
  • Erçolak, V., Kara, O., Günaldı, M., Usul Afşar, C., Bozkurt Duman, B., Açıkalın, A., Ergin, M., & Erdoğan, S. (2014). Bilateral primary adrenal non-Hodgkin lymphoma. Turkish Journal of Haematology, 31(2), 205–206. https://doi.org/10.4274/tjh.2013.0195
  • Gunaldi, M., Kara, I. O., Duman, B. B., Afsar, C. U., Ergin, M., & Avci, A. (2014). A new approach to the treatment of metastatic paraganglioma: Sorafenib. Cancer Research and Treatment, 46(4), 411–414.
  • Sözütek, D., Yanık, S., Akkoca, A. N., Sözütek, A., Ozdemir, Z. T., Avşar, C. U., Günaldı, M., Sahin, B., & Doron, F. (2014). Diagnostic and prognostic roles of DOG1 and Ki-67, in GIST patients with localized or advanced/metastatic disease. International Journal of Clinical and Experimental Medicine, 7(7), 1914–1922.
  • Ercolak, V., Paydas, S., Ergin, M., Ates, B. T., Duman, B. B., Gunaldi, M., & Afsar, C. U. (2014). Abdominal actinomycosis with multiple myeloma: A case report. Oncology Letters, 8(4), 1876–1878.
  • Paydaş, S., Ozdoğu, H., Günaldı, M., Haksöyler, V., Açıkalın, A., & Ergin, M. (2014). Extramedullary myeloid tumor involving the pancreas: A case report and review of the literature. Turkish Journal of Haematology, 31(3), 295–300. https://doi.org/10.4274/tjh.2013.0195
  • Günaldı, M., Erkisi, M., Afşar, C. U., Erçolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U. K., & Secilmis, A. (2014). Evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment. Pharmacology, 94(3–4), 183–189.
  • Afsar, C. U., Gunaldi, M., Kum, P., Sahin, B., Erkisi, M., Kara, I. O., Paydas, S., Duman, B. B., Ercolak, V., Karaca, F., Uyeturk, U., & Guner, S. I. (2014). Pancreatic carcinoma, thrombosis and mean platelet volume: Single center experience from the southeast region of Turkey. Asian Pacific Journal of Cancer Prevention, 15(21), 9143–9146.
  • Gunaldi, M., Duman, B. B., Afsar, C. U., Paydas, S., Erkisi, M., Kara, I. O., & Sahin, B. (2016). Risk factors for developing cardiotoxicity of trastuzumab in breast cancer patients: An observational single-centre study. Journal of Oncology Pharmacy Practice, 22(2), 242–247.
  • Karaca, F., Afsar, C. U., Gunaldi, M., Erkurt, E., Ercolak, V., Sertdemir, Y., & Paydas, S. (2015). Alterations of ghrelin with weights and correlation among ghrelin, cytokine and survival in patients receiving chemoradiotherapy for gastrointestinal cancers. International Journal of Clinical and Experimental Medicine, 8(1), 876–882.
  • Okuturlar, Y., Gunaldi, M., Tiken, E. E., Oztosun, B., Inan, Y. O., Ercan, T., Tuna, S., Kaya, A. O., Harmankaya, O., & Kumbasar, A. (2015). Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pacific Journal of Cancer Prevention, 16(6), 2409–2412.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbasi, A., Kocoglu, H., Kural, A., Akarsu, C., Gunduz, U., & Tiken, E. E. (2015). Elevated serum levels of heat shock protein 70 are associated with breast cancer. Tohoku Journal of Experimental Medicine, 236(2), 97–102. https://doi.org/10.1620/tjem.236.97
  • Ercolak, V., Paydas, S., Bagir, E., Ergin, M., Seydaoglu, G., Celik, H., Yavu, B., Tanriverdi, K., Gunaldi, M., Afsar, C. U., & Duman, B. B. (2015). PRAME expression and its clinical relevance in Hodgkin's lymphoma. Acta Haematologica, 134(4), 199–207.
  • Gunaldi, M., Goksu, S., Erdem, D., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., Inan, Y. O., Genc, T. B., & Yildirim, M. (2015). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study. International Journal of Clinical and Experimental Medicine, 8(4), 5937–5942.
  • Günaldı, M., Afsar, C. U., Duman, B. B., Kara, I. O., Tatli, U., & Sahin, B. (2015). Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws. Oncology Letters, 10(1), 439–442.
  • Karabulut, M., Gunaldi, M., Alis, H., Afsar, C. U., Karabulut, S., Serilmez, M., Akarsu, C., Seyit, H., & Aykan, N. F. (2016). Serum nectin-2 levels are diagnostic and prognostic in patients with colorectal carcinoma. Clinical and Translational Oncology, 18(2), 160–171.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Mert, M., Harmankaya, O., Soylu, A., Karakaya, P., & Kumbasar, A. (2016). Serum paraoxonase 1 activity in patients with iron deficiency anemia. Archives of Medical Science, 12(4), 697–703. https://doi.org/10.5114/aoms.2015.48730
  • Okuturlar, Y., Ozkalemkas, F., Ener, B., Serin, S. O., Kazak, E., Ozcelik, T., Ozkocaman, V., Ozkan, H. A., Akalin, H., Gunaldi, M., & Ali, R. (2015). Serum galactomannan levels in the diagnosis of invasive aspergillosis. Korean Journal of Internal Medicine, 30(6), 899–905.
  • Ercolak, V., Sahin, B., Gunaldi, M., Duman, B. B., & Afsar, C. U. (2015). Efficacy of paclitaxel in the treatment of Kaposi sarcoma. European Review for Medical and Pharmacological Sciences, 19(21), 4095–4100.
  • Usul Afsar, C., Sahin, B., Gunaldi, M., Kılıc Bagir, E., Gumurdulu, D., Burgut, R., Erkisi, M., Kara, I. O., Paydas, S., Karaca, F., & Ercolak, V. (2015). Expression of fibroblast growth factor receptor 1, fibroblast growth factor 2, phosphatidyl inositol 3 phosphate kinase and their clinical and prognostic significance in squamous cell carcinoma of the lung. International Journal of Clinical and Experimental Pathology, 8(9), 9760–9771.
  • Gunaldi, M., Okuturlar, Y., Gedikbasi, A., Akarsu, C., Karabulut, M., & Kural, A. (2015). Diagnostic importance of S100A9 and S100A12 in breast cancer. Biomedicine & Pharmacotherapy, 76, 52–56. https://doi.org/10.1016/j.biopha.2015.10.029
  • Karabulut, M., Alis, H., Bas, K., Karabulut, S., Afsar, C. U., Oguz, H., Gunaldi, M., Akarsu, C., Kones, O., & Aykan, N. F. (2015). Clinical significance of serum claudin-1 and claudin-7 levels in patients with colorectal cancer. Molecular and Clinical Oncology, 3(6), 1255–1267.
  • Gunaldi, M., Kocoglu, H., Okuturlar, Y., Gedikbasi, A., Karabulut, M., & Hursitoglu, M. (2015). Heat shock protein 70 is a useful marker for predicting colorectal cancer. Journal of BUON, 20(6), 1464–1470.
  • Afsar, C. U., Gunaldı, M., Okuturlar, Y., Gedikbası, A., Tiken, E. E., Kahraman, S., Karaca, F., Ercolak, V., & Karabulut, M. (2015). Paraoxonase-1 and arylesterase activities in patients with colorectal cancer. International Journal of Clinical and Experimental Medicine, 8(11), 21599–21604.
  • Ekmen, N., Helvaci, A., Gunaldi, M., Sasani, H., & Yildirmak, S. T. (2016). Leptin as an important link between obesity and cardiovascular risk factors in men with acute myocardial infarction. Indian Heart Journal, 68(2), 132–137. https://doi.org/10.1016/j.ihj.2015.07.032
  • Kocoglu, H., Dogan, H., Oguz, B., Ocak Serin, S., Okuturlar, Y., Gunaldi, M., Erismis, B., Ozdemir, B., Tural, D., Hursitoglu, M., Harmankaya, O., & Kumbasar, A. (2016). Comparison of survival rates, tumor stages, and localization in obese and nonobese patients with gastric cancer. Gastroenterology Research and Practice, 2016, 9382750. https://doi.org/10.1155/2016/9382750
  • Gündüz, U. R., Gunaldi, M., Isiksacan, N., Gündüz, S., Okuturlar, Y., & Kocoglu, H. (2016). A new marker for breast cancer diagnosis, human epididymis protein 4: A preliminary study. Molecular and Clinical Oncology, 5(2), 355–360.
  • Tanriverdi, O., Menekse, S., Teker, F., Oktay, E., Nur Pilanc, K., Gunaldi, M., Kocar, M., Kacan, T., Bahceci, A., Avci, N., Akman, T., Cokmert, S., Yesil-Cinkir, H., & Teoman Yanmaz, M. (2016). The mean platelet volume may predict the development of isolated bone metastases in patients with breast cancer: A retrospective study of the Young Researchers Committee of the Turkish Oncology Group (TOG). Journal of BUON, 21(4), 840–850.
  • Gunaldi, M., Kose, F., Demirci, N. S., Gunduz, S., Ozdemir, N., Kocoglu, H., Okuturlar, Y., Sedef, A. M., Erdem, D., Goksu, S. S., Erdem, G. U., & Yildirim, M. (2018). Adding taxane to platin-5-fluorouracil combination does not improve survival rate in patients ≥ 65 years of age with advanced gastric cancer: A retrospective multicenter study. Journal of BUON, 23(2), 416–421.
  • Gunaldi, M., Isiksacan, N., Kocoglu, H., Okuturlar, Y., Gunaldi, O., Topcu, T. O., & Karabulut, M. (2018). The value of serum survivin level in early diagnosis of cancer. Journal of Cancer Research and Therapeutics, 14(3), 570–573.
  • Topcu, T. O., Ozdemir, F., Kavgaci, H., Gunaldi, M., Kocoglu, H., Imamoglu, G. I., Mentese, A., Yaman, S. O., Orem, A., & Aydin, F. (2018). The clinical importance of serum urokinase plasminogen activator receptor and carbonic anhydrase IX levels and the effect of anthracycline-based adjuvant chemotherapy on these biomarkers in breast cancer. Journal of Cancer Research and Therapeutics, 14(3), 608–613.
  • Okuturlar, Y., Gunaldi, M., Kocoglu, H., Hursitoglu, M., Gedikbasi, A., Acarer, D., Harmankaya, O., & Kumbasar, A. (2018). Serum paraoxonase and arylesterase can be useful markers to predict neoadjuvant chemotherapy requirement in patients with breast cancer. Journal of Cancer Research and Therapeutics, 14(Suppl), S362–S367.
  • Şişman, H., Özgen, R., Baysal, D., Sarıakçalı, N., Öztürk, S., Kum, P., Gürel, D., Kanarığ, D., Aslaner, E., Akıl, Y., & Günaldı, M. (2014). Measurement of the knowledge level about breast self-exam among the female employees of a university hospital, Turkey. Asia-Pacific Journal of Oncology Nursing, 1(1), 40–45.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The lifetime cost-of-disease (CoD) of metastatic colorectal cancer (mCRC) in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A448.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-of-disease of metastatic/inoperable gastrointestinal stromal tumors in Turkey: An expert panel approach for estimation of costs. Value in Health, 18(7), A449.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of metastatic/inoperable gastrointestinal stromal tumors in Turkey. Value in Health, 18(7), A455.
  • Deger, C., Telli, F., Gunaldi, M., Keskin, S., Saglam, S., Ozdemir, O., Sar, C., Parali, E., Erdal, E., Sumer, F., Ozel, O., & Asan, S. (2015). The cost-effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer (mCRC) who have progressed after standard therapies in Turkey. Value in Health, 18(7), A458.
  • Gunaldi, M., Erdem, D., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Aksoy, H., & Yildirim, M. (2016). Platelet distribution width as a predictor of metastasis in gastric cancer patients. Journal of Gastrointestinal Cancer. Advance online publication. https://doi.org/10.1007/s12029-016-9886-5
  • Demir, A., Molinas Mandel, N., Paydas, S., Demir, G., Er, O., Turhal, N. S., Bavbek, S., Eralp, Y., Saip, P. M., Güler, E. N., Aydıner, A., Uluç, B. O., Kılıçkap, S., Üskent, N., Karadurmuş, N., Kaplan, M. A., Yanmaz, M. T., Demir, H., Alan, O., Korkmaz, T., Olgun, P., Uysal, Ö. S., Altundağ, K., Gündüz, Ş., Günaldı, M., Sarı, M., Beypınar, İ., & Başaran, G. (2020). [Article title unavailable]. Balkan Medical Journal, 37(2), 104–107. https://doi.org/10.4274/balkanmedj.galenos.2020.2020.2.3
Доклады, Представленные на Международных Научных Конференциях и Опубликованные в Трудах:
  • Gunaldi, M., Kara, I. O., Afsar, C. U., & Duman, B. B. (2012, June 1–5). Sorafenib in the treatment of metastatic paraganglioma: A case report [Постерный доклад]. 2012 ASCO Annual Meeting, Chicago, IL, United States.
  • Duman, B. B., Gunaldi, M., Tasdogan, B. E., Afsar, C. U., Paydas, S., & Gumurdulu, Y. (2012, May–June). Nonalcoholic fatty liver disease after adjuvant therapy in nonmetastatic breast cancer [Постерный доклад]. ASCO Annual Meeting, Chicago, IL, United States.
  • Gunaldi, M., Sahin, B., & Tatlı, U. (2011). Osteonecrosis of the jaw in cancer patients treated with bisphosphonates [Постерный доклад]. Mediterranean Multidisciplinary Oncology Forum Congress.
  • Tiken, E. E., Günaldı, M., Okuturlar, Y., & Tuna, S. (2014, September 30–October 2). The evaluation of synchronous bilateral breast cancer patients [Постерный доклад]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Günaldı, M., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014, September 30–October 2). Evaluation of body mass index in breast cancer patients [Постерный доклад]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014, September 30–October 2). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Постерный доклад]. International Breast Cancer Conference, Istanbul, Turkey.
  • Gunaldi, M., Erkisi, M., Afsar, C. U., Ercolak, V., Paydas, S., Kara, I. O., Sahin, B., Gulec, U., & Secilmis, A. (2014). The evaluation of endometrial thickness and bone mineral density based on CYP2D6 polymorphisms in Turkish breast cancer patients receiving tamoxifen treatment [Постерный доклад]. ASCO Annual Meeting, Chicago, IL, United States.
  • Afsar, C. U., Sahin, B., Gumurdulu, D., Kılıc Bagir, E., Burgut, R., Erkisi, M., Kara, I. O., Gunaldi, M., & Ercolak, V. (2014, September 26–30). The evaluation of fibroblast growth factor receptor 1 (FGFR1), fibroblast growth factor 2 (FGF2), phosphatidylinositol 3 phosphate kinase (IP3K) expression and their clinical, prognostic significance in early and advanced stage of squamous cell carcinoma of the lung [Постерный доклад]. 39th ESMO Congress, Madrid, Spain.
  • Helvaci, A., Çorbacıoğlu, E., & Günaldı, M. (2010, April 15–18). Acute coronary syndrome and its relation with diabetes mellitus and antidiabetic drug [Постерный доклад]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Okuturlar, Y., Gedikbasi, A., Akalin, N., Gunaldi, M., Yilmaz, D., Karakaya, P., Mert, M., & Harmankaya, O. (2014, June 22–26). Effects of iron therapy on paraoxonase and arylesterase activities in patients with iron deficiency anemia [Постерный доклад]. IFCC WorldLab Istanbul 2014, 22nd International Congress of Clinical Chemistry and Laboratory Medicine, Istanbul, Turkey.
  • Afsar, C. U., Gunaldi, M., Okuturlar, Y., Gedikbaşı, A., & Kural, A. (2014). Paraoxonase and arylesterase activities in patients with colorectal cancer [Постерный доклад]. Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Afsar, C. U., Okuturlar, Y., Gedikbaşı, A., Kural, A., & Tiken, E. E. (2014). Can heat shock protein 70 be a target therapy in breast cancer? [Постерный доклад]. Advances in Predictive & Personalized Medicine.
  • Okuturlar, Y., Gunaldi, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2014). Breast cancer and paraoxonase activity [Постерный доклад]. Advances in Predictive & Personalized Medicine.
  • Isıksacan, N., Koşer, M., Gunaldi, M., & Ördekçi, S. (2014). C-reactive protein (CRP) measurement using point of care (POC) devices [Постерный доклад]. Advances in Predictive & Personalized Medicine.
  • Oztosun, B., Okuturlar, Y., Gunaldi, M., Soyluk, S., Biricik, Ö., Mert, M., Sayilan, S., Orman, M., & Kaptanoğulları, Ö. (2014). An aggressive malignant insulinoma: A case report [Постерный доклад]. European Congress of Endocrinology.
  • Abbasoğlu, D., Gunaldi, M., Sivas, H., Yakıcıer, M. C., & Hızel, H. C. (2014). The factors affecting UGT1A1 enzyme activity of irinotecan drug response in Turkish population [Постерный доклад]. 7th Santorini Conference on Systems Personalized Health and Therapy.
  • Gunaldi, M., & Helvaci, A. (2010, April 15–18). Alteration in serum levels of selenium and glutathione peroxidase in acute myocardial infarction [Постерный доклад]. 59th ESCVS International Congress in conjunction with the 6th Congress of Update in Cardiology and Cardiovascular Surgery, Cesme, Izmir, Turkey.
  • Günaldı, M., Tiken, E. E., Okuturlar, Y., Tuna, S., & Kapan, S. (2014). Neoadjuvant chemotherapy in breast cancer patients: Single centre experience [Постерный доклад]. International Breast Cancer Conference, Istanbul, Turkey.
  • Okuturlar, Y., Tiken, E. E., Tuna, S., Oztosun, B., Inan, Y., Ercan, T., Harmankaya, O., & Kumbasar, B. (2014). Evaluation of body mass index in breast cancer patients [Постерный доклад]. International Breast Cancer Conference, Istanbul, Turkey.
  • Günaldı, M., Gürgenyataği, D., Göksu, S., Gülenay, Ş., Yildirim, M., Tiken, E., Okuturlar, Y., & Kahraman, S. (2014). A factor that predicts occurrence of metastasis on stomach cancer patients: PDW [Постерный доклад]. 4th International Gastrointestinal Cancer Conference.
  • Okuturlar, Y., Günaldı, M., Gedikbaşı, A., Kural, A., & Acarer, D. (2015). Breast cancer and paraoxonase activity [Постерный доклад]. Cancer International Symposium on Advances in Predictive & Personalized Medicine.
  • Gunaldi, M., Goksu, S., Gunduz, S., Okuturlar, Y., Tiken, E., Kahraman, S., & Isıksacan, N. (2015, September 6–9). Prognostic impact of platelet/lymphocyte and neutrophil/lymphocyte ratios in patients with gastric cancer: A multicenter study [Постерный доклад]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Okuturlar, Y., Kural, A., Akarsu, C., Karabulut, M., & Gedikbasi, A. (2015, September 6–9). Clinical importance of S100A9 and S100A12 in breast cancer [Постерный доклад]. 4th European Congress of Immunology, Vienna, Austria.
  • Gunaldi, M., Isıksacan, N., Okuturlar, Y., Kocoglu, H., & Gunaldi, O. (2015, September 6–9). Clinical significance of serum survivin in cancer patients [Постерный доклад]. 4th European Congress of Immunology, Vienna, Austria.
Написанные Национальные/Международные Книги или Главы Книг:
    • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite (Классификация, применение и токсичность химиотерапевтических средств и молекулярно-таргетной терапии). In H. Onat (Ed.), Kanser kemoterapi el kitabı (Руководство по химиотерапии рака). Çukurova Nobel Kitabevi. (Глава книги)
    • Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı (Резервуар Оммаи). In Nöroşirurjide şant cerrahisi (Шунтирующая хирургия в нейрохирургии). Selen Yayıncılık. (Глава книги)
    Написанные Национальные/Международные Книги:
    • Günaldı, M. (2022, Февраль). Gastrointestinal sistem kanserlerinde güncel yaklaşımlar – Metastatik iyi farklılaşmış gastrointestinal ve pankreas nöroendokrin tümörlerde tedavi (Современные подходы к раку желудочно-кишечного тракта – Лечение метастатических высокодифференцированных нейроэндокринных опухолей желудочно-кишечного тракта и поджелудочной железы). (Книга)
    • Günaldı, Ö., & Günaldı, M. (2014). Ommaya rezervuarı (Резервуар Оммаи). In Nöroşirurjide şant cerrahisi (Шунтирующая хирургия в нейрохирургии). Selen Yayıncılık. (Книга)
    • Yıldırım, Y., Günaldı, M., & Karaarslan, S. (2013). Kemoterapötik ve moleküler hedefe yönelik tedavide sınıflama, kullanım ve toksisite (Классификация, применение и токсичность химиотерапевтических средств и молекулярно-таргетной терапии). In H. Onat (Ed.), Kanser kemoterapi el kitabı (Руководство по химиотерапии рака). Çukurova Nobel Kitabevi. (Книга)
    Статьи, Опубликованные в Национальных Рецензируемых Журналах:
    • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Kara, İ. O., & Şahin, B. (2012). Sorafenib ilişkili üç farklı deri toksisitesi: Olgu sunumu (Три различных кожных токсичности, связанные с сорафенибом: Сообщение о случае). Turkish Journal of Dermatology.
    • Yılmaz, G., Adaş, M., Helvacı, A., Altıntaş, N., & Günaldi, M. (2013). Evaluation of respiratory functions in subclinical and clinical hypothyroidism. Journal of Turgut Ozal Medical Center.
    • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Sever, N. (2014). İnvaziv lobuler meme kanserinin mideye metastazı: Olgu sunumu (Метастазирование инвазивного лобулярного рака молочной железы в желудок: Сообщение о случае). Türk Onkoloji Dergisi, 29(4), 157–161. https://doi.org/10.5505/tjoncol.2014.1178
    • Günaldi, M., Duman, B. B., Afşar, Ç. U., Günaldı, Ö., & Şahin, B. (2014). Temporal kemik yerleşimli langerhans hücreli histiositozis: Bir olgu sunumu (Гистоцитоз из клеток Лангерганса с локализацией в височной кости: Сообщение о случае). Göztepe Tıp Dergisi.
    • Karaca, F., Erçolak, V., Afşar, Ç. U., & Günaldi, M. (2015). Memenin diffüz büyük B hücreli lenfoması (Диффузная крупноклеточная B-клеточная лимфома молочной железы). Çukurova Medical Journal.
    • Günaldi, M., & Köksal Erkiş, M. (2014). Glioblastome multiformede kemoterapi (Химиотерапия при мультиформной глиобластоме). Klinik Tıp Bilimleri.
    • Gözkaman, A., Okuturlar, Y., Kanat, Ö., Günaldi, M., Serin, S. O., Saydaroğlu, Ö., Kumbasar, A., & Evrensel, T. (2015). Küçük hücreli akciğer kanserli hastalarda C-Kit (CD117) ekspresyonu (Экспрессия C-Kit (CD117) у пациентов с мелкоклеточным раком легкого). Haseki Tıp Bülteni, 53, 67–71. https://doi.org/10.4274/haseki.2078
    • Okuturlar, Y., Günaldi, M., Tiken, E. E., Tuna, S., Öztosun, B., Özdeminan, Y., Ercan, T., Harmankaya, Ö., & Kumbasar, A. (2015). Fazla kilo ve obezitenin meme kanseri alt tipleri üzerine etkisi (Влияние избыточного веса и ожирения на подтипы рака молочной железы). Journal of Clinical and Analytical Medicine.
    • Tiken, E. E., Günaldi, M., Okuturlar, Y., & Tuna, S. (2015). Senkron bilateral meme kanserli hastaların değerlendirilmesi (Оценка пациентов с синхронным двусторонним раком молочной железы). Istanbul Medical Journal. Advance online publication.
    • Okuturlar, Y., Mert, M., Soyluk, Ö., Enki, S., Sayilan, S., Gönenç, M., Günaldi, M., Kumbasar, A., Aliş, H., & Harmankaya, Ö. (2015). İleri yaşta görülen nadir bir hipoglisemi nedeni: İnsülinoma (Редкая причина гипогликемии в пожилом возрасте: Инсулинома). Bakırköy Tıp Dergisi.
    • Günaldi, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Köksal Erkiş, M., Kara, İ. O., Şahin, B., & Gönlüsen, G. (2014). Osteosarkomların retrospektif değerlendirmesi (Ретроспективная оценка остеосарком). Journal of Clinical and Analytical Medicine.
    • Günaldi, M. (2014). Meme kanseri risk faktörleri (Факторы риска рака молочной железы). Klinik Tıp Aile Hekimliği Dergisi.
    • Özkara, İ. Ö., & Günaldi, M. (2014). Mide kanseri: Önleme, risk faktörleri ve prognoz (Рак желудка: Профилактика, факторы риска и прогноз). Klinik Tıp Aile Hekimliği Dergisi.

    Доклады, Представленные на Научных Конференциях и Опубликованные в Трудаx:
    • Günaldı, M., Duman, B. B., Erçolak, V., Afşar, Ç. U., Paydaş, S., Kara, İ. O., Erkişi, M., & Şahin, B. (2012, March 21–25). Trastuzumab ilişkili kardiyotoksisiteye epirubisin ve doksorubisinin katkısının araştırılması (Исследование вклада эпирубицина и доксорубицина в кардиотоксичность, связанную с трастузумабом) [Постерный доклад]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Günaldı, M., Paydaş, S., Afşar, Ç. U., Erçolak, V., Duman, B. B., & Doran, F. (2012, March 21–25). Tuberoskleroz ve malign melanom birlikteliği (Сосуществование туберозного склероза и злокачественной меланомы) [Постерный доклад]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Günaldı, M. (2012, March 21–25). Bilateral over metastazı ile tanı konan primer appendiks adenokarsinomu (Первичная аденокарцинома аппендикса, диагностированная с билатеральными метастазами в яичники) [Постерный доклад]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Günaldı, M., Erkişi, M., Afşar, Ç. U., Duman, B. B., & Erçolak, V. (2012, March 21–25). Richter sendromu (Синдром Рихтера) [Постерный доклад]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Duman, B. B., Afşar, Ç. U., Günaldı, M., Erkişi, M., Kara, İ. O., Şahin, B., & Kum, P. (2013, April 19–23). Meme kanserli hastalarda adjuvan/neoadjuvan kemoterapi deneyimimiz (Наш опыт адъювантной/неоадъювантной химиотерапии у пациенток с раком молочной железы) [Постерный доклад]. 20. Ulusal Kanser Kongresi, Antalya, Turkey.
    • Günaldı, M., Kara, İ. O., Afşar, Ç. U., Erçolak, V., & Duman, B. B. (2012, March 21–25). Akromegaliye eşlik eden malign mezankimal tümör (Злокачественная мезенхимальная опухоль, сопутствующая акромегалии) [Постерный доклад]. 4. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Erçolak, V., Paydaş, S., Şeydaoğlu, G., Günaldı, M., Afşar, Ç. U., & Duman, B. B. (2013). Hodgkin lenfoma olgularında retrospektif değerlendirme (Ретроспективная оценка случаев лимфомы Ходжкина) [Постерный доклад]. 5. Tıbbi Onkoloji Kongresi, Antalya, Turkey.
    • Турецкая ассоциация медицинской онкологии (TTOD) – Совет директоров (2020–2022)
    • Междисциплинарная ассоциация онкологии (IDOD)
    • Турецкая ассоциация нейроонкологии
    • Европейское общество медицинской онкологии (ESMO)
    • Доцент д-р Метин Каран, премия за лучшую статью (2013)
    • Премия Ассоциации медицинской онкологии за лучший доклад (2012)
    • Третье место за лучший постерный доклад
    • Курс биологических методов лечения от А до Я (2023)
    • Курсы Турецкой ассоциации медицинской онкологии (2020–2022)
    • Конгресс по паллиативной помощи (2018)
    • Симпозиум по медицинской онкологии в Улудаге (2018)

    Задайте вопрос специалистам
    Описание формы еще не введено